Αρχική
Τύποι καρκίνου
Θεραπείες
Υποστήριξη
Νέα
Κέντρα και ογκολόγοι
Αναζήτηση
Τετάρτη, Νοέμβριος 11, 2026
Ogkologos.com
Αρχική
Τύποι καρκίνου
Θεραπείες
Υποστήριξη
Νέα
Κέντρα και ογκολόγοι
Αρχική
Δημιουργοί
Δημοσιεύσεις από Ogkologos
Ogkologos
4397 ΔΗΜΟΣΙΕΥΣΕΙΣ
0 ΣΧΟΛΙΑ
Resource Round-Up: 2Unstoppable
Ogkologos
-
16 Μαΐου, 2023
0
First immunotherapy approved for cervical cancer in England and Scotland
Ogkologos
-
16 Μαΐου, 2023
0
Can the New “Omics” on the Block Find Liver Cancer in...
Ogkologos
-
15 Μαΐου, 2023
0
Long-Term Benefit of Sotorasib in Patients with Pretreated KRASG12C-Mutated NSCLC
Ogkologos
-
15 Μαΐου, 2023
0
A Propensity Score Matched Study Supports the Use of Allogeneic HSCT...
Ogkologos
-
12 Μαΐου, 2023
0
What Is a Living Will and Why Should You Create One...
Ogkologos
-
11 Μαΐου, 2023
0
Cancer waiting times: Latest updates and analysis
Ogkologos
-
11 Μαΐου, 2023
0
Coming Full Circle on Cancer and Extrachromosomal DNA
Ogkologos
-
10 Μαΐου, 2023
0
ESMO Launches Living Guidelines to Enhance the Usability of its Clinical...
Ogkologos
-
10 Μαΐου, 2023
0
ESMO Launches Living Guidelines to Enhance the Usability of its Clinical...
Ogkologos
-
10 Μαΐου, 2023
0
1
...
132
133
134
...
440
Σελίδα 133 από 440
MOST POPULAR
Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for...
8 Ιουλίου, 2025
FDA Says Breast Implant Cancer Risk Is Not Enough to Warrant...
3 Μαΐου, 2019
Why Have Thyroid Cancer Diagnoses Spiked for US Women?
28 Σεπτεμβρίου, 2021
FDA Grants Regular Approval to Dostarlimab-gxly for dMMR Endometrial Cancer
20 Φεβρουαρίου, 2023
Φόρτωση περισσοτέρων
HOT NEWS
Targeted Therapy for Claudin-18.2 and Combined PD-1 and TIGIT Immunotherapy for...
EMA Recommends Extension of Therapeutic Indications for Retifanlimab
Beginning Surveillance Colonoscopy After 5 Years from Removal of High-Risk Adenomas...
Many Men with Penile Cancer Do Not Get Recommended Treatments, Study...
Ελληνικά
English (UK)
